Central serous retinopathy or Central serous chorioretinopathy (CSCR) is a condition characterized by a focal area (or areas) of fluid accumulation underneath the retina and retinal pigment epithelium (pigment epithelial detachment). Most commonly this occurs in the macular area, but may occur in other parts of the retina. It, typically, occurs in middle-aged men and is thought to be associated with Type A personality (although this is relatively tenuous). Most cases resolve spontaneously within a few weeks, although, occasionally it can take months or years. Most patients retain good vision after an episode of resolved CSCR. There can, however, be permanent damage to the vision. This tends to be worse if the problem becomes recurrent or chronic. Patients with CSCR often describe their vision as being distorted, blurred for reading or objects looking smaller (micropsia) when compared to the normal eye. In cases which persist or recur; treatment can be considered. The main treatment modality is "Photo Dynamic Therapy" (PDT). This treatment involves injection of a special dye (verteporforin) into the blood circulation. A type of laser is then used to treat the abnormal area of choroid and retina. This treatment is not perfect and sometimes does not work, even if repeated. This treatment can also damage the choroid and retina which can result in permanent damage to the vision. For these reasons, PDT is not offered in straight-forward cases of CSCR. In recurrent or persistent cases the risks must be weighed up against the benefits. Other treatment options include anti-VEGF injections and other types of laser therapy. The cause of CSCR is not known.
Fluorescein angiogram CSCR
SD-OCT scan of CSCR
www.retinalspecialist.com The Virtual Home of Niladri (Ted) Saha 2009